Ananda Pharma (AQSE:ANA) ROE % Adjusted to Book Value: 0.00% (As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma ROE % Adjusted to Book Value?

Ananda Pharma AQSE:ANA +14.58% ROE % Adjusted to Book Value is 0.00% as of Jul. 2025. The stock has 5 warning signs investors should review.

Ananda Pharma's ROE % for the quarter that ended in Jul. 2025 was -322.58%. Ananda Pharma's PB Ratio for the quarter that ended in Jul. 2025 was N/A. Ananda Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2025 was N/A.

Ananda Pharma ROE % Adjusted to Book Value Related Terms

Ananda Pharma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma ROE % Adjusted to Book Value Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -60.23 0.00 -37.89 0.00 0.00

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.19 0.00 0.00 0.00 0.00

AQSE:ANA vs ZTS, UTHR, VTRS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ananda Pharma ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's ROE % Adjusted to Book Value falls into.


Ananda Pharma ROE % Adjusted to Book Value Calculation

Ananda Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-304.15% / N/A
=N/A

Ananda Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-322.58% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Ananda Pharma (AQSE:ANA) has a ROE % Adjusted to Book Value of 0.00% as of Jul. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ananda Pharma and its competitors.
Is Ananda Pharma's ROE % Adjusted to Book Value too high?
Ananda Pharma's current ROE % Adjusted to Book Value is 0.00%.
How does Ananda Pharma's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Ananda Pharma's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ananda Pharma and its competitors. Ananda Pharma's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (AQSE:ANA) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Ananda Pharma (AQSE:ANA), the current ROE % Adjusted to Book Value is 0.00% as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ananda Pharma Business Description

Other Exchanges 1FX:Germany
Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).